NFKB1 and neoplasm: Although specific inflammatory cell populations were not dissected, these results provide evidence that macrophage populations may be shifted towards an “anti-tumor” M1 phenotype by reducing tumor NF-κB activity with a systemic NF-κB inhibitor.